NONQUALIFIED STOCK OPTION AGREEMENT PHASERX, INC.Nonqualified Stock Option Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company Industry
INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 2nd, 2016 Company Industry Jurisdiction
AMENDMENT NO.3 TO CONSULTING AGREEMENTConsulting Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company IndustryThis Amendment No. 3 to Consulting Agreement (this “Amendment”), dated _June 30, __________, 2016, is entered into between PhaseRx, Inc., a Delaware corporation having a place of business at 410 West Harrison Street, Seattle, WA 98119 (the “Company”) and Paul H. Johnson, Ph.D., having a place of business at 12020 211th Place SE, Snohomish, Washington 98296 (the “Consultant”).
AMENDMENT TO INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company IndustryThis AMENDMENT TO INCENTIVE STOCK OPTION AGREEMENT (this “Amendment”), dated as of , 2016, is made and entered into by and between PhaseRx, Inc., a Delaware corporation (the “Company”), and (the “Participant”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Incentive Stock Option Agreement by and between the Company and the Participant, dated , 2016 (the “Option Agreement”), and in the PhaseRx 2016 Long-Term Incentive Plan.
AMENDMENT TO NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company IndustryThis AMENDMENT TO NONQUALIFIED STOCK OPTION AGREEMENT (this “Amendment”), dated as of , 2016, is made and entered into by and between PhaseRx, Inc., a Delaware corporation (the “Company”), and (the “Participant”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Nonqualified Stock Option Agreement by and between the Company and the Participant, dated , 2016 (the “Option Agreement”), and in the PhaseRx 2016 Long-Term Incentive Plan.
AMENDMENT TO NONQUALIFIED STOCK OPTION AGREEMENTNonqualified Stock Option Agreement • August 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2016 Company IndustryThis AMENDMENT TO NONQUALIFIED STOCK OPTION AGREEMENT (this “Amendment”), dated as of June , 2016, is made and entered into by and between PhaseRx, Inc., a Delaware corporation (the “Company”), and (the “Participant”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Nonqualified Stock Option Agreement by and between the Company and the Participant, dated June 1, 2016 (the “Option Agreement”), and in the PhaseRx 2016 Long-Term Incentive Plan.